annual current liabilities:
$103.55M+$45.45M(+78.24%)Summary
- As of today (September 16, 2025), SNDX annual total current liabilities is $103.55 million, with the most recent change of +$45.45 million (+78.24%) on December 31, 2024.
- During the last 3 years, SNDX annual current liabilities has risen by +$82.87 million (+400.65%).
- SNDX annual current liabilities is now at all-time high.
Performance
SNDX Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$112.99M+$18.44M(+19.50%)Summary
- As of today (September 16, 2025), SNDX quarterly total current liabilities is $112.99 million, with the most recent change of +$18.44 million (+19.50%) on June 30, 2025.
- Over the past year, SNDX quarterly current liabilities has increased by +$70.52 million (+166.03%).
- SNDX quarterly current liabilities is now at all-time high.
Performance
SNDX quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SNDX Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +78.2% | +166.0% |
| 3 y3 years | +400.6% | +265.4% |
| 5 y5 years | +463.8% | +806.3% |
SNDX Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +400.6% | at high | +443.1% |
| 5 y | 5-year | at high | +463.8% | at high | +806.3% |
| alltime | all time | at high | +3693.0% | at high | +5321.6% |
SNDX Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $112.99M(+19.5%) |
| Mar 2025 | - | $94.55M(-8.7%) |
| Dec 2024 | $103.55M(+78.2%) | $103.55M(+74.4%) |
| Sep 2024 | - | $59.38M(+39.8%) |
| Jun 2024 | - | $42.47M(-16.4%) |
| Mar 2024 | - | $50.80M(-12.5%) |
| Dec 2023 | $58.10M(+99.9%) | $58.10M(+48.3%) |
| Sep 2023 | - | $39.17M(+29.9%) |
| Jun 2023 | - | $30.17M(+27.2%) |
| Mar 2023 | - | $23.72M(-18.4%) |
| Dec 2022 | $29.07M(+40.5%) | $29.07M(+39.7%) |
| Sep 2022 | - | $20.80M(-32.7%) |
| Jun 2022 | - | $30.93M(+1.2%) |
| Mar 2022 | - | $30.55M(+47.7%) |
| Dec 2021 | $20.68M(+9.6%) | $20.68M(-28.0%) |
| Sep 2021 | - | $28.71M(+18.2%) |
| Jun 2021 | - | $24.29M(-1.1%) |
| Mar 2021 | - | $24.57M(+30.2%) |
| Dec 2020 | $18.87M(+2.7%) | $18.87M(+24.5%) |
| Sep 2020 | - | $15.16M(+21.6%) |
| Jun 2020 | - | $12.47M(-33.7%) |
| Mar 2020 | - | $18.79M(+2.3%) |
| Dec 2019 | $18.37M | $18.37M(+0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $18.29M(+4.6%) |
| Jun 2019 | - | $17.49M(+11.7%) |
| Mar 2019 | - | $15.66M(-2.8%) |
| Dec 2018 | $16.11M(+1.9%) | $16.11M(-5.4%) |
| Sep 2018 | - | $17.02M(-11.8%) |
| Jun 2018 | - | $19.30M(+14.1%) |
| Mar 2018 | - | $16.91M(+7.0%) |
| Dec 2017 | $15.80M(+52.4%) | $15.80M(+11.2%) |
| Sep 2017 | - | $14.21M(+23.5%) |
| Jun 2017 | - | $11.51M(+4.7%) |
| Mar 2017 | - | $10.99M(+6.0%) |
| Dec 2016 | $10.37M(+113.9%) | $10.37M(+13.3%) |
| Sep 2016 | - | $9.15M(+39.6%) |
| Jun 2016 | - | $6.55M(-6.9%) |
| Mar 2016 | - | $7.04M(-27.2%) |
| Dec 2015 | $4.85M(-53.2%) | - |
| Dec 2014 | $10.35M(+279.0%) | - |
| Sep 2014 | - | $9.66M(+109.0%) |
| Jun 2014 | - | $4.62M(+121.8%) |
| Mar 2014 | - | $2.08M(-23.7%) |
| Dec 2013 | $2.73M(-89.1%) | $2.73M(-72.3%) |
| Sep 2013 | - | $9.85M |
| Dec 2012 | $25.10M(+87.3%) | - |
| Dec 2011 | $13.41M | - |
FAQ
- What is Syndax Pharmaceuticals, Inc. annual total current liabilities?
- What is the all time high annual current liabilities for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. annual current liabilities year-on-year change?
- What is Syndax Pharmaceuticals, Inc. quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
What is Syndax Pharmaceuticals, Inc. annual total current liabilities?
The current annual current liabilities of SNDX is $103.55M
What is the all time high annual current liabilities for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high annual total current liabilities is $103.55M
What is Syndax Pharmaceuticals, Inc. annual current liabilities year-on-year change?
Over the past year, SNDX annual total current liabilities has changed by +$45.45M (+78.24%)
What is Syndax Pharmaceuticals, Inc. quarterly total current liabilities?
The current quarterly current liabilities of SNDX is $112.99M
What is the all time high quarterly current liabilities for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high quarterly total current liabilities is $112.99M
What is Syndax Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
Over the past year, SNDX quarterly total current liabilities has changed by +$70.52M (+166.03%)